Pesquisar um ensaio clínico
Outras opções de pesquisa
11 Resultado(s)
Ensaio em fase de recrutamento = 
; Ensaio a decorrer = 
; Ensaio concluído = 
; Financiado por um membro do IRDiRC = 
; Membro de uma ERN = 
Ensaio (s) clínico (s) nacional (is)
ESTADOS UNIDOS
Connecticut
CHESHIRE
ARISE: A phase 3 multicenter, randomized, placebo-controlled study of SBC-102 in patients with Lysosomal Acid Lipase Deficiency - DE
Alexion Pharmaceuticals, Inc.
ESTADOS UNIDOS
Connecticut
CHESHIRE
A Multicenter, Open-Label Study of Sebelipase Alfa in Patients With Lysosomal Acid Lipase Deficiency (Phase II) - DE
Alexion Pharmaceuticals, Inc.
ESTADOS UNIDOS
Massachusetts
LEXINGTON
ARISE: A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency - CA
Synageva BioPharma Corp
FRANCA
GRAND-EST
VANDOEUVRE-LÈS-NANCY
ARISE: A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency (Phase III) - FR
CHU de Nancy - Hôpitaux de Brabois
Service de médecine infantile
FRANCA
ILE-DE-FRANCE
PARIS
LAL-CL04: An Open Label Multicenter Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 in Adult Subjects With Liver Dysfunction Due to Lysosomal Acid Lipase Deficiency Who Previously Received Treatment in Study LAL-CL01 (Phase II) - FR
Hôpital Necker-Enfants Malades
Service des Maladies Métaboliques pédiatriques
GRECIA
GREECE
ADDRESS: NOT PROVIDED - GR
ARISE (LAL-CL02): A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency (Phase III) - GR
Institution: Information not provided - GR
PAISES BAIXOS
Noord-Holland
AMSTERDAM
A Multicenter, Open-Label Study of Sebelipase Alfa in Patients With Lysosomal Acid Lipase Deficiency (Phase II) - NL
Amsterdam UMC, locatie AMC
Polikliniek Kindermetabole Ziekten
POLONIA
Kraków
ADDRESS: NOT PROVIDED - PL
ARISE (LAL-CL02): A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency (Phase III) - PL
Institution: Information not provided - PL
REPUBLICA CHECA
Capital City Prague
ADDRESS: NOT PROVIDED - CZ
ARISE (LAL-CL02): A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency (Phase III) - CZ
Institution: Information not provided - CZ
Ensaio (s) clínico (s) multinacional (ais)
REINO UNIDO
Greater Manchester
ADDRESS: NOT PROVIDED - UK
LAL-CL01: An Open Label Multicenter Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SBC-102 in Adult Patients With Liver Dysfunction Due to Lysosomal Acid Lipase Deficiency (Phase I)
Institution: Information not provided - UK
REINO UNIDO
Greater Manchester
ADDRESS: NOT PROVIDED - UK